177 related articles for article (PubMed ID: 26763431)
21. Neutrophil Adhesion Is a Prerequisite for Antibody-Mediated Proteolytic Tissue Damage in Experimental Models of Epidermolysis Bullosa Acquisita.
Yu X; Akbarzadeh R; Pieper M; Scholzen T; Gehrig S; Schultz C; Zillikens D; König P; Petersen F
J Invest Dermatol; 2018 Sep; 138(9):1990-1998. PubMed ID: 29559343
[TBL] [Abstract][Full Text] [Related]
22. Dimethyl fumarate modulates neutrophil extracellular trap formation in a glutathione- and superoxide-dependent manner.
Hoffmann JHO; Schaekel K; Hartl D; Enk AH; Hadaschik EN
Br J Dermatol; 2018 Jan; 178(1):207-214. PubMed ID: 28733990
[TBL] [Abstract][Full Text] [Related]
23. Propranolol Is an Effective Topical and Systemic Treatment Option for Experimental Epidermolysis Bullosa Acquisita.
Stüssel P; Schulze Dieckhoff K; Künzel S; Hartmann V; Gupta Y; Kaiser G; Veldkamp W; Vidarsson G; Visser R; Ghorbanalipoor S; Matsumoto K; Krause M; Petersen F; Kalies K; Ludwig RJ; Bieber K
J Invest Dermatol; 2020 Dec; 140(12):2408-2420. PubMed ID: 32450072
[TBL] [Abstract][Full Text] [Related]
24. Pathogenesis of epidermolysis bullosa acquisita.
Ludwig RJ; Zillikens D
Dermatol Clin; 2011 Jul; 29(3):493-501, xi. PubMed ID: 21605817
[TBL] [Abstract][Full Text] [Related]
25. Pathogenesis of epidermolysis bullosa acquisita, an autoimmune subepidermal bullous disease.
Hashimoto T; Ishii N; Ohata C; Furumura M
J Pathol; 2012 Sep; 228(1):1-7. PubMed ID: 22692770
[TBL] [Abstract][Full Text] [Related]
26. Autoimmunity to type VII collagen: epidermolysis bullosa acquisita.
Remington J; Chen M; Burnett J; Woodley DT
Curr Dir Autoimmun; 2008; 10():195-205. PubMed ID: 18460887
[TBL] [Abstract][Full Text] [Related]
27. Generation of antibodies of distinct subclasses and specificity is linked to H2s in an active mouse model of epidermolysis bullosa acquisita.
Ludwig RJ; Recke A; Bieber K; Müller S; Marques Ade C; Banczyk D; Hirose M; Kasperkiewicz M; Ishii N; Schmidt E; Westermann J; Zillikens D; Ibrahim SM
J Invest Dermatol; 2011 Jan; 131(1):167-76. PubMed ID: 20720563
[TBL] [Abstract][Full Text] [Related]
28. Epidermolysis bullosa acquisita: what's new?
Ishii N; Hamada T; Dainichi T; Karashima T; Nakama T; Yasumoto S; Zillikens D; Hashimoto T
J Dermatol; 2010 Mar; 37(3):220-30. PubMed ID: 20507385
[TBL] [Abstract][Full Text] [Related]
29. Autoantibody-induced intestinal inflammation and weight loss in experimental epidermolysis bullosa acquisita.
Ishii N; Recke A; Mihai S; Hirose M; Hashimoto T; Zillikens D; Ludwig RJ
J Pathol; 2011 Jun; 224(2):234-44. PubMed ID: 21381035
[TBL] [Abstract][Full Text] [Related]
30. Angiostatin inhibits activation and migration of neutrophils.
Aulakh GK; Balachandran Y; Liu L; Singh B
Cell Tissue Res; 2014 Feb; 355(2):375-96. PubMed ID: 24297047
[TBL] [Abstract][Full Text] [Related]
31. Anti-type VII collagen autoantibodies, detected by enzyme-linked immunosorbent assay, fluctuate in parallel with clinical severity in patients with epidermolysis bullosa acquisita.
Ito Y; Kasai H; Yoshida T; Saleh MA; Amagai M; Yamagami J
J Dermatol; 2013 Nov; 40(11):864-8. PubMed ID: 24127822
[TBL] [Abstract][Full Text] [Related]
32. Binding of avian IgY to type VII collagen does not activate complement and leucocytes and fails to induce subepidermal blistering in mice.
Sesarman A; Mihai S; Chiriac MT; Olaru F; Sitaru AG; Thurman JM; Zillikens D; Sitaru C
Br J Dermatol; 2008 Mar; 158(3):463-71. PubMed ID: 18205879
[TBL] [Abstract][Full Text] [Related]
33. Evidence that anti-type VII collagen antibodies are pathogenic and responsible for the clinical, histological, and immunological features of epidermolysis bullosa acquisita.
Woodley DT; Chang C; Saadat P; Ram R; Liu Z; Chen M
J Invest Dermatol; 2005 May; 124(5):958-64. PubMed ID: 15854036
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of Glucose Metabolism Abrogates the Effector Phase of Bullous Pemphigoid-Like Epidermolysis Bullosa Acquisita.
Schilf P; Schmitz M; Derenda-Hell A; Thieme M; Bremer T; Vaeth M; Zillikens D; Sadik CD
J Invest Dermatol; 2021 Jul; 141(7):1646-1655.e3. PubMed ID: 33609554
[TBL] [Abstract][Full Text] [Related]
35. Familial epidermolysis bullosa acquisita.
Noe MH; Chen M; Woodley DT; Fairley JA
Dermatol Online J; 2008 Dec; 14(12):2. PubMed ID: 19265615
[TBL] [Abstract][Full Text] [Related]
36. Induction of dermal-epidermal separation in mice by passive transfer of antibodies specific to type VII collagen.
Sitaru C; Mihai S; Otto C; Chiriac MT; Hausser I; Dotterweich B; Saito H; Rose C; Ishiko A; Zillikens D
J Clin Invest; 2005 Apr; 115(4):870-8. PubMed ID: 15841176
[TBL] [Abstract][Full Text] [Related]
37. Caspase-1-independent IL-1 release mediates blister formation in autoantibody-induced tissue injury through modulation of endothelial adhesion molecules.
Sadeghi H; Lockmann A; Hund AC; Samavedam UK; Pipi E; Vafia K; Hauenschild E; Kalies K; Pas HH; Jonkman MF; Iwata H; Recke A; Schön MP; Zillikens D; Schmidt E; Ludwig RJ
J Immunol; 2015 Apr; 194(8):3656-63. PubMed ID: 25795756
[TBL] [Abstract][Full Text] [Related]
38. A patient with both bullous pemphigoid and epidermolysis bullosa acquisita: an example of intermolecular epitope spreading.
Fairley JA; Woodley DT; Chen M; Giudice GJ; Lin MS
J Am Acad Dermatol; 2004 Jul; 51(1):118-22. PubMed ID: 15243536
[TBL] [Abstract][Full Text] [Related]
39. Induction of epidermolysis bullosa acquisita in mice by passive transfer of autoantibodies from patients.
Woodley DT; Ram R; Doostan A; Bandyopadhyay P; Huang Y; Remington J; Hou Y; Keene DR; Liu Z; Chen M
J Invest Dermatol; 2006 Jun; 126(6):1323-30. PubMed ID: 16543893
[TBL] [Abstract][Full Text] [Related]
40. Granulocyte-derived elastase and gelatinase B are required for dermal-epidermal separation induced by autoantibodies from patients with epidermolysis bullosa acquisita and bullous pemphigoid.
Shimanovich I; Mihai S; Oostingh GJ; Ilenchuk TT; Bröcker EB; Opdenakker G; Zillikens D; Sitaru C
J Pathol; 2004 Dec; 204(5):519-27. PubMed ID: 15538734
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
